Alerts will be sent to your verified email
Verify Email
VENUSREM
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Venus Remedies Limited is an Indian pharmaceutical company with a global presence, specializing in critical care and super specialty segments. It is dedicated to research, innovation, and delivering high-quality products worldwide.
Venus Remedies major competitors are Kwality Pharma, Jagsonpal Pharma, Lincoln Pharma, Syncom Formulations, Ind-Swift Lab., Fredun Pharma, Sakar Healthcare.
Market Cap of Venus Remedies is ₹1,060 Crs.
While the median market cap of its peers are ₹933 Crs.
Venus Remedies seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | Mar Sep | Mar Sep Dec | |||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
